Onyia Jude

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 42% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Onyia Jude's trades of Neurocrine Biosciences, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
433.95
Quantity 79,123
Value US$4,130,368
Transaction date
Proposed sale
Price
155.73
Quantity 11,000
Value US$1,713,030
Transaction date
Purchase
Price
0.25
Quantity 400,000
Value £100,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-06-01
PlS Planned sale
81,377 +32.6%
179.63
US$1,372,356 		81,377 +32.6% 179.63 US$1,372,356
2026-06-01 2026-06-01
PrS Proposed sale
79,123
433.95
US$4,130,368 		79,123 433.95 US$4,130,368
2026-05-29 2026-05-27
PlS Planned sale
58,502 +37.7%
257.79
US$2,969,876 		58,502 +37.7% 257.79 US$2,969,876
2026-05-27 2026-05-27
PrS Proposed sale
11,000
155.73
US$1,713,030 		11,000 155.73 US$1,713,030
2025-07-11 2025-07-09
PlS Planned sale
59,819 -76.6%
130.46
US$7,803,688 		59,819 -76.6% 130.46 US$7,803,688
2025-07-07 2025-07-02
PlS Planned sale
20,362 -52.7%
130.13
US$2,649,738 		20,362 -52.7% 130.13 US$2,649,738
2025-07-02 2025-07-02
PrS Proposed sale
80,181
128.00
US$10,263,168 		80,181 128.00 US$10,263,168
2025-02-14 2025-02-13
PlS Planned sale
1,447 -7.4%
116.75
US$168,933 		1,447 -7.4% 116.75 US$168,933
2025-02-14 2025-02-13
PlS Planned sale
1,432 -7.8%
116.83
US$167,306 		1,432 -7.8% 116.83 US$167,306
2025-02-13 2025-02-13
PrS Proposed sale
1,447
117.18
US$169,559 		1,447 117.18 US$169,559
2025-02-13 2025-02-13
PrS Proposed sale
1,432
117.18
US$167,802 		1,432 117.18 US$167,802
2025-02-04 2025-01-31
PlS Planned sale
126 -0.8%
152.97
US$19,274 		126 -0.8% 152.97 US$19,274
2025-01-31 2025-01-31
PrS Proposed sale
126
153.29
US$19,315 		126 153.29 US$19,315
2024-12-03 2024-11-29
PlS Planned sale
2,331 -13.1%
126.29
US$294,373 		2,331 -13.1% 126.29 US$294,373
2024-11-29 2024-11-29
PrS Proposed sale
2,331
126.59
US$295,081 		2,331 126.59 US$295,081
2024-02-15 2024-02-13
PlS Planned sale
1,432 -9.8%
132.94
US$190,371 		1,432 -9.8% 132.94 US$190,371
2024-02-13 2024-02-13
PrS Proposed sale
1,432
130.43
US$186,776 		1,432 130.43 US$186,776
2024-02-02 2024-01-31
PlS Planned sale
126 -1.1%
141.94
US$17,884 		126 -1.1% 141.94 US$17,884
2024-01-31 2024-01-31
PrS Proposed sale
126
142.06
US$17,900 		126 142.06 US$17,900
2023-12-01 2023-11-29
PlS Planned sale
2,331 -16.6%
113.57
US$264,733 		2,331 -16.6% 113.57 US$264,733
2023-11-29 2023-11-29
PrS Proposed sale
2,331
112.84
US$263,030 		2,331 112.84 US$263,030
2023-08-22 2023-08-22
PrS Proposed sale
3,198
108.32
US$346,407 		3,198 108.32 US$346,407
2023-08-23 2023-08-21
PlS Planned sale
3,198 -24.9%
107.37
US$343,368 		3,198 -24.9% 107.37 US$343,368
2023-02-08 2023-02-07
PlS Planned sale
4,508 -40.9%
102.30
US$461,166 		4,508 -40.9% 102.30 US$461,166
2023-02-02 2023-01-31
PlS Planned sale
126 -4.8%
108.48
US$13,668 		126 -4.8% 108.48 US$13,668
2022-12-01 2022-11-29
PlS Planned sale
2,331 -49.6%
121.90
US$284,160 		2,331 -49.6% 121.90 US$284,160
2021-08-18 2021-08-18
B Purchase
400,000
0.25
£100,000 		400,000 0.25 £100,000